Skip to main content
Top
Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 9/2018

01-09-2018 | Editorials

In asking the right questions, be cautious of confounding by indication

Authors: Donald Griesdale, MD, MPH, Philip M. Jones, MD, MSc

Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Issue 9/2018

Login to get access

Excerpt

If you are admitted to an intensive care unit (ICU) today, your chances of survival are better than they have ever been. In the past three decades, there has been a consistent reduction in ICU mortality, irrespective of the reason for admission.1 For example, in 2000, a patient admitted to an ICU in Australia and New Zealand with severe sepsis had a 35% risk of mortality.2 This absolute risk of dying had dropped to 18% by 2012. It is hard to point to a single intervention that can account for this marked improvement in outcome. In fact, many of the interventions that were enthusiastically adopted during this time (e.g., intensive insulin therapy, activated protein C, early goal-directed therapy) have subsequently been shown to be ineffective3,4 or even harmful.5 What then is driving this dramatic decrease in mortality? Rather than a single intervention, these improved outcomes are likely the result of the small incremental benefits from multiple factors and improved processes of care.6
Literature
1.
go back to reference Zimmerman JE, Kramer AA, Knaus WA. Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012. Crit Care 2013; 17: R81.PubMedPubMedCentralCrossRef Zimmerman JE, Kramer AA, Knaus WA. Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012. Crit Care 2013; 17: R81.PubMedPubMedCentralCrossRef
2.
go back to reference Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014; 311: 1308-16.PubMedCrossRef Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014; 311: 1308-16.PubMedCrossRef
3.
go back to reference ProCESS Investigators, Yealy DM, Kellum JA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370: 1683-93.CrossRef ProCESS Investigators, Yealy DM, Kellum JA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370: 1683-93.CrossRef
4.
go back to reference Ranieri VM, Thompson BT, Barie PS, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2013; 366: 2055-64.CrossRef Ranieri VM, Thompson BT, Barie PS, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2013; 366: 2055-64.CrossRef
5.
go back to reference NICE-SUGAR Investigators, Finfer S, Chittock DR et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-1297. NICE-SUGAR Investigators, Finfer S, Chittock DR et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-1297.
6.
go back to reference Hutchings A, Durand MA, Grieve R, et al. Evaluation of modernisation of adult critical care services in England: time series and cost effectiveness analysis. BMJ 2009; 339: b4353.PubMedPubMedCentralCrossRef Hutchings A, Durand MA, Grieve R, et al. Evaluation of modernisation of adult critical care services in England: time series and cost effectiveness analysis. BMJ 2009; 339: b4353.PubMedPubMedCentralCrossRef
7.
8.
go back to reference Hutchinson PJ, Kolias AG, Timofeev IS, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med 2016; 375: 1119-30.PubMedCrossRef Hutchinson PJ, Kolias AG, Timofeev IS, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med 2016; 375: 1119-30.PubMedCrossRef
9.
go back to reference Andrews PJ, Sinclair HL, Rodriguez A, et al. Hypothermia for intracranial hypertension after traumatic brain injury. N Engl J Med 2015; 373: 2403-12.PubMedCrossRef Andrews PJ, Sinclair HL, Rodriguez A, et al. Hypothermia for intracranial hypertension after traumatic brain injury. N Engl J Med 2015; 373: 2403-12.PubMedCrossRef
10.
go back to reference Gerges PR, Moore L, Leger C, Lauzier F, et al (2018) Intensity of care and withdrawal of life-sustaining therapies in severe traumatic brain injury patients: a post-hoc analysis of a multicentre retrospective cohort study. Can J Anesth 65. DOI: https://doi.org/10.1007/s12630-018-1171-6 Gerges PR, Moore L, Leger C, Lauzier F, et al (2018) Intensity of care and withdrawal of life-sustaining therapies in severe traumatic brain injury patients: a post-hoc analysis of a multicentre retrospective cohort study. Can J Anesth 65. DOI: https://​doi.​org/​10.​1007/​s12630-018-1171-6
11.
go back to reference Turgeon AF, Lauzier F, Simard JF, et al. Mortality associated with withdrawal of life-sustaining therapy for patients with severe traumatic brain injury: a Canadian multicentre cohort study. CMAJ 2011; 183: 1581-8.PubMedPubMedCentralCrossRef Turgeon AF, Lauzier F, Simard JF, et al. Mortality associated with withdrawal of life-sustaining therapy for patients with severe traumatic brain injury: a Canadian multicentre cohort study. CMAJ 2011; 183: 1581-8.PubMedPubMedCentralCrossRef
12.
go back to reference Salas M, Hofman A, Stricker BH. Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol 1999; 149: 981-3.PubMedCrossRef Salas M, Hofman A, Stricker BH. Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol 1999; 149: 981-3.PubMedCrossRef
13.
14.
go back to reference Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-5.PubMedCrossRef Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-5.PubMedCrossRef
15.
go back to reference Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007; 297: 278-85.PubMedPubMedCentralCrossRef Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007; 297: 278-85.PubMedPubMedCentralCrossRef
16.
go back to reference Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-61.PubMedCrossRef Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-61.PubMedCrossRef
17.
go back to reference Kramer AH, Zygun DA. Do neurocritical care units save lives? Measuring the impact of specialized ICUs. Neurocrit Care 2011; 14: 329-33.PubMedCrossRef Kramer AH, Zygun DA. Do neurocritical care units save lives? Measuring the impact of specialized ICUs. Neurocrit Care 2011; 14: 329-33.PubMedCrossRef
Metadata
Title
In asking the right questions, be cautious of confounding by indication
Authors
Donald Griesdale, MD, MPH
Philip M. Jones, MD, MSc
Publication date
01-09-2018
Publisher
Springer US
Published in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Issue 9/2018
Print ISSN: 0832-610X
Electronic ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-018-1172-5

Other articles of this Issue 9/2018

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 9/2018 Go to the issue